From Bio-Innovation to Health and Wealth Delivery in Tomorrow’s World
14 December at QEII Centre, Westminster, London
Genesis 2017 will build on the previous 16 years of experience in assembling a forum where industry executives, investors, academic researchers, policymakers and the expert advisers can exchange and debate their collective insight in order to provide true thought leadership for the sector, themselves and their stakeholders.
Our ability to investigate the biological processes linked to ill health is combining with our ability to collect, combine and interrogate ever increasing and complex data sets to enable researchers to generate innovate treatment hypotheses for better targeted and effective interventions. These interventions may be biochemical or mechanical and indeed in some cases preventative rather than therapeutic.
The previous Genesis showcased and debated how innovative science, technology, and business strategies were facilitating the transformation of knowledge into better outcomes for all stakeholders.
Under the overarching theme of “From Bio-Innovation to Health and Wealth Delivery in Tomorrow’s World”, our 17th Annual Genesis Conference, will take place on Thursday 14 December 2017 in London. The event will again engage all the key elements for those active in R&D, finance, policy-making and service provision across Life Sciences, Digital and Health Technology fields in creating a vision of where the sector is heading. Over 70 expert speakers and panelists will lead sessions discussing which approaches will deliver better outcomes for patients, investors, and payers.